Ngā Poutama: Consumer, family and whānau experience survey privacy impact statement
Privacy impact statement for Ngā Poutama: Consumer, family and whānau experience survey.
Advance care planning is the process of thinking about, talking about and planning for future health care and end of life care. This page provides information about advance care planning for consumers and clinicians.
Our quality improvement science education and training courses provide skills to address local improvement challenges, as well as building ability to draw on what is available nationally.
The Commission engages with the sector to improve the delivery of health care services though specific quality improvement programmes.
The Commission’s national Infection prevention and control (IPC) programme aims to improve patient outcomes by reducing the incidence and impact of healthcare associated infections (HAIs) within the New Zealand health and disability sector.
The mental health and addiction quality improvement programme is a national initiative working with the DHBs to ensure that people who experience mental health and addiction issues, and their whānau, receive high quality care.
Mortality review committees are statutory committees that review particular deaths, or the deaths of particular people, in order to learn how to best prevent these deaths.
In February 2018 Health Minister Hon. Dr David Clark initiated an independent review of the National Bowel Screening Programme.
The Health Quality & Safety Commission is contracted by the Accident Compensation Corporation (ACC) to provide support to the Te Hononga Whētuki ā-Motu | National Trauma Network.
Our programme’s aim is to ensure consumer and whānau engagement in the planning, delivery, and monitoring of health services and therefore a higher quality and safer health system.
The way we think about safety in the health sector has changed over recent years. We are increasingly recognising the health care system is a complex system that constantly adapts to change.
This programme establishes baseline measures and indicators which can be used to assess the quality of the health and disability system.
The Atlas of Healthcare Variation displays easy-to-use maps, graphs, tables and commentaries that highlight variations by geographic area in the provision and use of specific health services and health outcomes.
This page is for submitting data around quality & safety markers and Adverse Events.
Measuring the quality of health care and communicating the results in a variety of ways and settings is a powerful way to stimulate improvement.
Health sectors rely on data to improve quality. Our Measures Library provides technical documents and summaries, management and case documents, plus links to other resources like the Atlas of Healthcare Variation.
Open4Results highlights harm prevented and money saved through the improvements made by health services in areas where the Commission has a focus.
Patient experience is a vital but complex area. The Health Quality & Safety Commission conducts two national surveys to enable the collection, measurement and use of patient experience information on a regular basis.
A list of subscribed apps to view data published by the health quality intelligence programme.
The dashboard brings together everything the Health Quality & Safety Commission knows about local health systems in one place.
Quality accounts require health care providers to give an account for the quality of their services in a similar way to financial accounts showing how an organisation used its money.
Every year the Commission publishes a document we call A window on the quality of Aotearoa New Zealand’s health care. The Window provides a snapshot of the quality of health care in the country.
Support for people working in health during the COVID-19 pandemic. Find information about how you can support yourselves and others, including consumers, teams and colleagues which complements and aligns with Ministry of Health resources.
The Choosing Wisely campaign seeks to reduce harm from unnecessary and low-value tests and treatment.